High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$243K
$243,405
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-19
$26,130
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-19 | $26,130 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-18
$26,041
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-18 | $26,041 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2026-03-17
$26,032
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-17 | $26,032 | S | Form 4 |
|
TARS
S
Tarsus Pharmaceuticals, Inc.
Lin Elizabeth Yeu
• Officer • Chief Medical Officer
Sell to Cover
2025-12-16
$165,201
|
||||||
| TARS |
Tarsus Pharmaceuticals, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2025-12-16 | $165,201 | S | Form 4 |